Case Report
Small Cell Neuroendocrine Carcinoma of the Cervix in Pregnancy: A Case Report and Review
Table 1
Small cell neuroendocrine cervical cancer during pregnancy: literature review.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FIGO, International Federation of Gynecology and Obstetrics; GA, gestational age; NACT, neoadjuvant chemotherapy; EP, cisplatin+ etoposide; TP, Paclitaxel+ Cisplatin; TC, Paclitaxel+carboplatin; VAC,vincristine+doxorubicin+ cyclophosphamide; IEP, ifosfamide+ cisplatin+ etoposide; C/S, cesarean section; RH, radical hysterectomy; RT, Radical Trachelectomy; PLND, pelvic lymph node dissection; PALND, para-aortic node dissection; CCRT, chemoradiotherapy; DOD, dead of disease; NED, no evidence of disease. |